Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early versus delayed pramipexole treatment in new-onset Parkinson's disease
2005-004949-34Phase 4Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Parkinson's disease (PD) comparing Early pramipexole with Delayed pramipexole (initial placebo) (2 arms). Primary endpoint: Change in UPDRS parts I–III at 15 months. Started Mar 2006; status: completed.
02
Drugs
pramipexole
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2005-004949-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004949-34.